Skip to main content
. 2026 May 28;71(10):4696–4702. doi: 10.1007/s10620-026-09990-8

Table 2.

Clinical characteristics stratified by MH

Variables MH (+), (n = 68) MH (−), (n = 207) P value
Age (years) 53.9 ± 15.6 49.3 ± 15.8 0.037
Male (%) 39 (57.4) 121 (58.5) 0.873
Duration of UC (years) 10.5 ± 10 8.1 ± 8.4 0.018
BMI (kg/m2) 22.00 ± 3.47 22.65 ± 4.81 0.222
Current smoking (%) 3 (4.4) 15 (7.3) 0.001
Current drinking (%) 30 (44.1) 85 (41.1) 0.658
Medication for UC
5-aminosalicylates (%) 60 (88.2) 192 (92.8) 0.243
Prednisolone (%) 5 (7.4) 50 (24.2) 0.003
Thiopurines (%) 9 (13.2) 33 (15.9) 0.590
TNF-α monoclonal antibody (%) 2 (2.9) 12 (5.8) 0.353
Clinical remission (%) 67 (98.5) 96 (46.4) 0.001
Number of remaining teeth (n) 23.9 ± 7.1 24.9 ± 6.4 0.322
 < 20 teeth (%) 11 (16.2) 25 (12.1)
20–27 teeth (%) 25 (36.8) 65 (31.4)
28 teeth (%) 32 (47.1) 117 (56.5) 0.172
Frequency of tooth brushing (n) 2.0 ± 0.0 2.0 ± 0.0 0.319
 ≤ 1 time/day (%) 10 (14.7) 55 (26.6)
2 times/day (%) 32 (47.1) 97 (46.9)
 ≥ 3 times/day (%) 26 (38.2) 55 (26.6) 0.021

BMI Body Mass Index, UC ulcerative colitis, SD standard deviation, TNF tumor necrosis factor